VRTX: third_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/e9a6afa2-e4c8-4a9f-af5f-83c23942870f/","filing_uuid":"e9a6afa2-e4c8-4a9f-af5f-83c23942870f","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/e9a6afa2-e4c8-4a9f-af5f-83c23942870f/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Mike McKay","dt_posted":"2026-10-19T17:33:46-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1050 17th Street NW","registrant_address_2":"Suite 550","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20036","registrant":{"id":400703105,"url":"https://lda.gov/api/v1/registrants/400703105/","house_registrant_id":null,"name":"EMPIRE CONSULTING GROUP","description":"Government Relations","address_1":"1050 17th Street NW","address_2":"Suite 550","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20036","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MIKE MCKAY","contact_telephone":"+1 202-787-5740","dt_updated":"2026-07-27T21:03:40.855794-04:00"},"client":{"id":212057,"url":"https://lda.gov/api/v1/clients/212057/","client_id":280,"name":"VERTEX PHARMACEUTICALS INCORPORATED","general_description":"Biotechnology company","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-08-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to Kidney health, HR 1227 Alternatives to Pain Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":53388,"prefix":null,"prefix_display":null,"first_name":"MIKE","nickname":null,"middle_name":null,"last_name":"MCKAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107217,"prefix":null,"prefix_display":null,"first_name":"E.","nickname":null,"middle_name":"BRANDON","last_name":"GARRETT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149092,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"HAYES","suffix":null,"suffix_display":null},"covered_position":"Deputy Director, Office of Public Engagement, The White House; Director, National Security Council, The White House; U.S. Diplomat, Department of State; Legislative Fellow, U.S. House of Representatives","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}